July 19, 2010 – CIVCO’s new RFSuite is designed with the capability to support the requirements set out by the Radiation Therapy Readiness Check Initiative, which was recently presented to the U.S. Food and Drug Administration by the Medical Imaging Technology Association (MITA).

Designed to implement additional patient protection features, the plan encourages clinicians to confirm the correct patient is being treated, the correct treatment plan is delivered as intended and the radiation therapy accessories and patient are positioned correctly prior to treatment. CIVCO’s RFSuite system will work in conjunction with this plan by confirming patient identity and verifying therapy accessories, thereby providing technologists, physicists and physicians with additional checkpoints to enable accurate and safe radiation therapy procedures.

RFSuite and other CIVCO solutions are providing the clinical community with the tools needed to address the new regulations and requirements designed to enhance safety and ensure the effective delivery of radiation therapy. RFSuite’s “hands free” design will also enhance the efficiency of the treatment verification process.

Radiation therapy is a crucial element in the effective treatment of cancer and is responsible for curing millions of patients worldwide. Over the past year, a number of radiation therapy mistreatments have occurred both in the United States and abroad, motivating government agencies to provide new safety recommendations. The Joint Commission (JCAHO) and the Code of Federal Regulations (42 CFR 482 Sec. 482.21) require the hospital to develop, implement and maintain an effective, ongoing, hospital-wide, data-driven quality assessment and performance improvement program. RFSuite is a unique and innovative way to ensure the safe and effective delivery of radiation therapy to millions of patients each year.


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now